HIGHLIGHTS
- who: Andreas GeretschlÅger from the Patients with locally advanced HL-SCC [American Joint Committee on Cancer (AJCC) stage III or IV] treated with curative IMRT treatment between January , and December , at the Department of Radiation Oncology, Inselspital, Bern University Hospital were retrospectively assessedIneligibility criteria included patients older than , years, initial Karnofsky Performance Status (KPS) less than, %, history of another malignancy within , years of diagnosis, prior RT to the head and neck, histology other than squamous cell carcinoma and distant metastatic disease. Patients who underwent radical surgical procedures to the primary tumor were excluded, but functional tumor . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.